 | | Q8K | | Name: | 11-cyclopropyl-14-(2-hydroxyethyl)-8,11,14,18,19,22-hexazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2(23),3,5,15(22),16,19-heptaen-7-one | | Formula: | C22 H24 N6 O2 | | SMILES: | OCCN1C=CN(CCNC(=O)c2cccc(c2)c3cnn4ccc1nc34)C5CC5 | | InChi: | InChI=1S/C22H24N6O2/c29-13-12-27-11-10-26(18-4-5-18)9-7-23-22(30)17-3-1-2-16(14-17)19-15-24-28-8-6-20(27)25-21(19)28/h1-3,6,8,10-11,14-15,18,29H,4-5,7,9,12-13H2,(H,23,30)/b11-10+ | | Definition date: | 2020-05-26 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | Q8Q | | Name: | 11-methyl-8,11,14,18,19,22-hexazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2(23),3,5,15(22),16,19-heptaen-7-one | | Formula: | C18 H20 N6 O | | SMILES: | CN1CCNC(=O)c2cccc(c2)c3cnn4C=CC(=Nc34)NCC1 | | InChi: | InChI=1S/C18H20N6O/c1-23-9-6-19-16-5-8-24-17(22-16)15(12-21-24)13-3-2-4-14(11-13)18(25)20-7-10-23/h2-5,8,11-12H,6-7,9-10H2,1H3,(H,19,22)(H,20,25) | | Definition date: | 2020-05-26 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | Q8T | | Name: | 11,15-dimethyl-6-(4-methylpiperazin-1-yl)-8-oxa-2,11,15,19,21,23-hexazatetracyclo[15.6.1.13,7.020,24]pentacosa-1(23),3(25),4,6,17,20(24),21-heptaen-10-one | | Formula: | C25 H34 N8 O2 | | SMILES: | CN1CCN(CC1)c2ccc3Nc4ncnc5[nH]cc(CN(C)CCCN(C)C(=O)COc2c3)c45 | | InChi: | InChI=1S/C25H34N8O2/c1-30-9-11-33(12-10-30)20-6-5-19-13-21(20)35-16-22(34)32(3)8-4-7-31(2)15-18-14-26-24-23(18)25(29-19)28-17-27-24/h5-6,13-14,17H,4,7-12,15-16H2,1-3H3,(H2,26,27,28,29) | | Definition date: | 2020-05-26 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | Q8W | | Name: | 10-(2-morpholin-4-ylethyl)-7-oxa-10,13,17,18,21-pentazatetracyclo[12.5.2.12,6.017,20]docosa-1(20),2(22),3,5,14(21),15,18-heptaene | | Formula: | C22 H26 N6 O2 | | SMILES: | C1CN(CCN2CCOCC2)C=COc3cccc(c3)c4cnn5C=CC(=Nc45)N1 | | InChi: | InChI=1S/C22H26N6O2/c1-2-18-16-19(3-1)30-15-12-26(8-9-27-10-13-29-14-11-27)7-5-23-21-4-6-28-22(25-21)20(18)17-24-28/h1-4,6,12,15-17H,5,7-11,13-14H2,(H,23,25)/b15-12+ | | Definition date: | 2020-05-26 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | Q98 | | Name: | 11-oxa-8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | | Formula: | C17 H17 N5 O2 | | SMILES: | O=C1NCCOCCNc2ccn3ncc(c4cccc1c4)c3n2 | | InChi: | InChI=1S/C17H17N5O2/c23-17-13-3-1-2-12(10-13)14-11-20-22-7-4-15(21-16(14)22)18-5-8-24-9-6-19-17/h1-4,7,10-11H,5-6,8-9H2,(H,18,21)(H,19,23) | | Definition date: | 2020-05-27 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | QNJ | | Name: | (3beta,5beta,14beta,17alpha)-cholestan-3-ol | | Formula: | C27 H48 O | | SMILES: | C1C3(C(CC(C1)O)CCC2C4C(CCC23)(C)C(CC4)C(CCCC(C)C)C)C | | InChi: | InChI=1S/C27H48O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-25,28H,6-17H2,1-5H3/t19-,20-,21+,22+,23-,24+,25+,26+,27-/m1/s1 | | Definition date: | 2019-11-25 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (3beta,5beta,14beta,17alpha)-cholestan-3-ol |
|
 | | Q9B | | Name: | 8,14,18,19,22-pentazatetracyclo[13.5.2.12,6.018,21]tricosa-1(21),2,4,6(23),15(22),16,19-heptaen-7-one | | Formula: | C18 H19 N5 O | | SMILES: | O=C1NCCCCCNc2ccn3ncc(c4cccc1c4)c3n2 | | InChi: | InChI=1S/C18H19N5O/c24-18-14-6-4-5-13(11-14)15-12-21-23-10-7-16(22-17(15)23)19-8-2-1-3-9-20-18/h4-7,10-12H,1-3,8-9H2,(H,19,22)(H,20,24) | | Definition date: | 2020-05-27 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 |
|
 | | QNP | | Name: | (2S)-1-(nonanoyloxy)-3-(phosphonooxy)propan-2-yl tetradecanoate | | Formula: | C26 H51 O8 P | | SMILES: | CCCCCCCCC(=O)OCC(COP(O)(=O)O)OC(CCCCCCCCCCCCC)=O | | InChi: | InChI=1S/C26H51O8P/c1-3-5-7-9-11-12-13-14-15-17-19-21-26(28)34-24(23-33-35(29,30)31)22-32-25(27)20-18-16-10-8-6-4-2/h24H,3-23H2,1-2H3,(H2,29,30,31)/t24-/m0/s1 | | Definition date: | 2019-11-25 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (2S)-1-(nonanoyloxy)-3-(phosphonooxy)propan-2-yl tetradecanoate |
|
 | | U0A | | Name: | 11-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide | | Formula: | C22 H19 N3 O4 S2 | | SMILES: | c14c(cc(cc1)C(=O)NCCc2ccc(cc2)S(N)(=O)=O)NC(c3ccccc3S4)=O | | InChi: | InChI=1S/C22H19N3O4S2/c23-31(28,29)16-8-5-14(6-9-16)11-12-24-21(26)15-7-10-20-18(13-15)25-22(27)17-3-1-2-4-19(17)30-20/h1-10,13H,11-12H2,(H,24,26)(H,25,27)(H2,23,28,29) | | Definition date: | 2020-04-06 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 11-oxo-N-[2-(4-sulfamoylphenyl)ethyl]-10,11-dihydrodibenzo[b,f][1,4]thiazepine-8-carboxamide |
|
 | | R8A | | Name: | (2-aminopyridin-3-yl)methanol | | Formula: | C6 H8 N2 O | | SMILES: | c1nc(N)c(CO)cc1 | | InChi: | InChI=1S/C6H8N2O/c7-6-5(4-9)2-1-3-8-6/h1-3,9H,4H2,(H2,7,8) | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (2-aminopyridin-3-yl)methanol |
|
 | | RM7 | | Name: | 2-[(4-amino-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide | | Formula: | C20 H29 N5 O S2 | | SMILES: | C(CNC(CSc1nc(N)c2c(n1)sc3c2CCCCC3)=O)N4CCCCC4 | | InChi: | InChI=1S/C20H29N5OS2/c21-18-17-14-7-3-1-4-8-15(14)28-19(17)24-20(23-18)27-13-16(26)22-9-12-25-10-5-2-6-11-25/h1-13H2,(H,22,26)(H2,21,23,24) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(4-amino-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide |
|
 | | RMG | | Name: | 2-{[3-(piperidin-1-yl)propyl]sulfanyl}-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-amine | | Formula: | C19 H28 N4 S2 | | SMILES: | C1CCCCN1CCCSc2nc(N)c3c(n2)sc4c3CCCCC4 | | InChi: | InChI=1S/C19H28N4S2/c20-17-16-14-8-3-1-4-9-15(14)25-18(16)22-19(21-17)24-13-7-12-23-10-5-2-6-11-23/h1-13H2,(H2,20,21,22) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-{[3-(piperidin-1-yl)propyl]sulfanyl}-6,7,8,9-tetrahydro-5H-cyclohepta[4,5]thieno[2,3-d]pyrimidin-4-amine |
|
 | | RMJ | | Name: | 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide | | Formula: | C18 H25 N5 O S2 | | SMILES: | C(CNC(CSc1nc(N)c2c(n1)sc3c2CCC3)=O)N4CCCCC4 | | InChi: | InChI=1S/C18H25N5OS2/c19-16-15-12-5-4-6-13(12)26-17(15)22-18(21-16)25-11-14(24)20-7-10-23-8-2-1-3-9-23/h1-11H2,(H,20,24)(H2,19,21,22) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(piperidin-1-yl)ethyl]acetamide |
|
 | | R8P | | Name: | (1S)-1-(4-nitrophenyl)ethan-1-ol | | Formula: | C8 H9 N O3 | | SMILES: | c1cc(ccc1[N+]([O-])=O)C(C)O | | InChi: | InChI=1S/C8H9NO3/c1-6(10)7-2-4-8(5-3-7)9(11)12/h2-6,10H,1H3/t6-/m0/s1 | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (1S)-1-(4-nitrophenyl)ethan-1-ol |
|
 | | R8V | | Name: | (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one | | Formula: | C9 H9 N O2 | | SMILES: | c1cc2c(cc1)C(N(C)C2O)=O | | InChi: | InChI=1S/C9H9NO2/c1-10-8(11)6-4-2-3-5-7(6)9(10)12/h2-5,8,11H,1H3/t8-/m0/s1 | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one |
|
 | | RMS | | Name: | 2-{[3-(piperidin-1-yl)propyl]sulfanyl}-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-amine | | Formula: | C17 H24 N4 S2 | | SMILES: | C4N(CCCSc1nc(N)c2c3c(sc2n1)CCC3)CCCC4 | | InChi: | InChI=1S/C17H24N4S2/c18-15-14-12-6-4-7-13(12)23-16(14)20-17(19-15)22-11-5-10-21-8-2-1-3-9-21/h1-11H2,(H2,18,19,20) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-{[3-(piperidin-1-yl)propyl]sulfanyl}-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-amine |
|
 | | RMV | | Name: | 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(diethylamino)ethyl]acetamide | | Formula: | C17 H25 N5 O S2 | | SMILES: | C(C)N(CCNC(CSc1nc(c2c(n1)sc3c2CCC3)N)=O)CC | | InChi: | InChI=1S/C17H25N5OS2/c1-3-22(4-2)9-8-19-13(23)10-24-17-20-15(18)14-11-6-5-7-12(11)25-16(14)21-17/h3-10H2,1-2H3,(H,19,23)(H2,18,20,21) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(4-amino-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(diethylamino)ethyl]acetamide |
|
 | | T9G | | Name: | 2-[(1R)-1-aminopropyl]phenol | | Formula: | C9 H13 N O | | SMILES: | c1cccc(O)c1C(N)CC | | InChi: | InChI=1S/C9H13NO/c1-2-8(10)7-5-3-4-6-9(7)11/h3-6,8,11H,2,10H2,1H3/t8-/m1/s1 | | Definition date: | 2020-03-18 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(1R)-1-aminopropyl]phenol |
|
 | | R97 | | Name: | 2-[(4-methyl-1,3-thiazol-2-yl)methyl]pyridine | | Formula: | C10 H10 N2 S | | SMILES: | C(c1ccccn1)c2nc(C)cs2 | | InChi: | InChI=1S/C10H10N2S/c1-8-7-13-10(12-8)6-9-4-2-3-5-11-9/h2-5,7H,6H2,1H3 | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(4-methyl-1,3-thiazol-2-yl)methyl]pyridine |
|
 | | RN4 | | Name: | (7S)-7-phenyl-2-{[3-(piperidin-1-yl)propyl]sulfanyl}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-amine | | Formula: | C24 H30 N4 S2 | | SMILES: | C1CCCCN1CCCSc2nc(N)c5c(n2)sc3c5CCC(C3)c4ccccc4 | | InChi: | InChI=1S/C24H30N4S2/c25-22-21-19-11-10-18(17-8-3-1-4-9-17)16-20(19)30-23(21)27-24(26-22)29-15-7-14-28-12-5-2-6-13-28/h1,3-4,8-9,18H,2,5-7,10-16H2,(H2,25,26,27)/t18-/m0/s1 | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (7S)-7-phenyl-2-{[3-(piperidin-1-yl)propyl]sulfanyl}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4-amine |
|
 | | RN7 | | Name: | 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide | | Formula: | C18 H25 N5 O2 S2 | | SMILES: | C3Cc2c1c(N)nc(nc1sc2CC3)SCC(NCCN4CCOCC4)=O | | InChi: | InChI=1S/C18H25N5O2S2/c19-16-15-12-3-1-2-4-13(12)27-17(15)22-18(21-16)26-11-14(24)20-5-6-23-7-9-25-10-8-23/h1-11H2,(H,20,24)(H2,19,21,22) | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-[(4-amino-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]-N-[2-(morpholin-4-yl)ethyl]acetamide |
|
 | | R9G | | Name: | (3-methoxyphenyl)(pyrrolidin-1-yl)methanone | | Formula: | C12 H15 N O2 | | SMILES: | c2c(C(N1CCCC1)=O)cc(cc2)OC | | InChi: | InChI=1S/C12H15NO2/c1-15-11-6-4-5-10(9-11)12(14)13-7-2-3-8-13/h4-6,9H,2-3,7-8H2,1H3 | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (3-methoxyphenyl)(pyrrolidin-1-yl)methanone |
|
 | | R9J | | Name: | 2-methyl-N-(4-methylphenyl)-L-alanine | | Formula: | C11 H15 N O2 | | SMILES: | c1(ccc(cc1)C)NC(C)(C)C(O)=O | | InChi: | InChI=1S/C11H15NO2/c1-8-4-6-9(7-5-8)12-11(2,3)10(13)14/h4-7,12H,1-3H3,(H,13,14) | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 2-methyl-N-(4-methylphenyl)-L-alanine |
|
 | | R9M | | Name: | 3-(1,3-thiazol-2-yl)propanoic acid | | Formula: | C6 H7 N O2 S | | SMILES: | C(C(O)=O)Cc1nccs1 | | InChi: | InChI=1S/C6H7NO2S/c8-6(9)2-1-5-7-3-4-10-5/h3-4H,1-2H2,(H,8,9) | | Definition date: | 2020-02-10 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | 3-(1,3-thiazol-2-yl)propanoic acid |
|
 | | RNJ | | Name: | (7S)-7-methyl-2-{[3-(piperidin-1-yl)propyl]sulfanyl}-7,8-dihydro[1]benzothieno[2,3-d]pyrimidin-4-amine | | Formula: | C19 H26 N4 S2 | | SMILES: | C4CCCN(CCCSc1nc(c2c(n1)sc3c2C=CC(C3)C)N)C4 | | InChi: | InChI=1S/C19H26N4S2/c1-13-6-7-14-15(12-13)25-18-16(14)17(20)21-19(22-18)24-11-5-10-23-8-3-2-4-9-23/h6-7,13H,2-5,8-12H2,1H3,(H2,20,21,22)/t13-/m1/s1 | | Definition date: | 2020-02-17 | | Last modified: | 2020-05-29 | | Release date: | 2020-06-03 | | Identifier: | (7S)-7-methyl-2-{[3-(piperidin-1-yl)propyl]sulfanyl}-7,8-dihydro[1]benzothieno[2,3-d]pyrimidin-4-amine |
|